What clinical and histopathological stages characterize infantile haemangiomas, and why are they critical when planning dermatological laser procedures? Key Insights for Optimal Laser Timing

Infantile haemangiomas are dynamic vascular tumours, not static birthmarks. They typically begin with a subtle precursor lesion, enter a period of rapid proliferation, mature into more dilated vascular structures, and then undergo slow involution with fibrosis and fatty replacement. These clinical and histopathological stages matter because laser treatment must be matched to the lesion’s activity, depth, location, and current risk; the wrong timing or settings can produce ineffective treatment, ulceration, or unnecessary tissue injury.

The same haemangioma can require different management at different stages. Active, deep, hyperperfused growth is not approached like residual superficial telangiectasia after involution, and accurate staging must precede any dermatological laser procedure.

How Infantile Haemangiomas Evolve

The Prodromal Phase

The earliest phase may appear as a red or pale macule, telangiectasia, anemic patch, or faint reddish-blue mark. The lesion may be difficult to distinguish clinically from a capillary malformation or another neonatal skin abnormality.

On colour-coded duplex sonography, the area may show altered skin architecture with a relatively low-echo or poorly structured centre and no established pathological vascular network. This phase reflects the beginning of lesion development rather than a fully formed tumour.

The Initial Phase

The lesion begins to lose the normal appearance of the skin and develops increasing thickness or induration. Vascularity may initially be more evident at the margins than in the centre.

This transitional phase is clinically important because apparent enlargement may accelerate quickly. A lesion that appears modest at one examination can become substantially thicker or more extensive over the following weeks.

The Proliferative Phase

During proliferation, the haemangioma becomes brighter red, more elevated, and increasingly infiltrative. Growth may involve both the dermis and subcutaneous tissue, producing a mixed or predominantly deep lesion.

Histopathologically, this phase is characterized by:

• High endothelial-cell turnover
• Plump, proliferating endothelial cells
• Dense capillary networks
• Increased mast-cell activity
• High vascular perfusion and arterial feeding vessels

Sonography typically demonstrates marked intratumoral hyperperfusion, dense central vessel networks, and arterial flow patterns. This is the biologically active phase in which the lesion has the greatest potential for rapid enlargement, ulceration, functional compromise, or disfigurement.

The Maturation Phase

Growth slows during maturation, and the lesion may become paler or more violaceous. The vascular network becomes less densely packed, while individual vessel lumina enlarge and develop more cavernous-like characteristics.

Histologically, this represents a shift away from cellular endothelial proliferation toward larger, more established vascular spaces. Sonography may show reduced central vessel density and a more echogenic or hyperechoic centre as the internal composition changes.

The Involuting or Regression Phase

Involution occurs gradually and may continue for years. Clinically, the lesion may become softer, paler, wrinkled, or hypopigmented, although residual induration, redundant skin, telangiectasia, or pigmentary change may remain.

Histopathological features include:

• Progressive interstitial fibrosis
• Fatty infiltration
• Reduced cellularity
• Loss of the dense proliferative vascular network
• Replacement of vascular tissue by fibrofatty tissue

Colour-coded duplex sonography generally confirms declining or absent tumour vascularity, with more circumscribed hyperechoic areas and loss of the earlier hyperperfused pattern.

Why Histopathology Changes Laser Planning

Endothelial Activity Determines Treatment Context

A proliferating haemangioma contains actively dividing endothelial cells and a high-flow vascular network. It is therefore biologically different from an involuted lesion containing residual superficial vessels, fibrofatty tissue, and altered skin.

Laser energy primarily produces photothermal injury to blood vessels, with oxyhaemoglobin serving as the relevant chromophore. The expected benefit, risk, and depth of effect depend on whether the target is a superficial residual vessel or part of an actively expanding, deeper vascular tumour.

Depth Determines Whether a Laser Can Reach the Target

Haemangiomas may be:

• Cutaneous, involving primarily superficial skin
• Subcutaneous, extending beneath the skin
• Mixed, involving both compartments

A superficial vascular laser may be appropriate for selected cutaneous vessels or post-involution telangiectasias, but it may not adequately treat a deep component. Conversely, using a deeply penetrating or high-energy approach on a superficial lesion can increase the risk of burns, ulceration, scarring, and pigmentary change.

Location Changes the Risk-Benefit Calculation

The same biological stage carries different consequences depending on anatomical site. Lesions near the eye, nose, lips, airway, genital region, or other functionally important structures require particularly careful assessment.

In these locations, treatment decisions must account for depth, tissue thickness, risk of ulceration, distortion of developing structures, and the likelihood that delayed treatment could cause permanent functional or cosmetic effects.

When Laser Treatment May Be Considered

During Active Proliferation

Laser treatment during proliferation is a specialized decision rather than a routine response to every growing lesion. The primary management of problematic infantile haemangiomas may involve specialist medical therapy, particularly systemic propranolol, while laser can have a role in selected superficial, ulcerated, or otherwise clinically indicated lesions.

If laser is considered, the operator must establish whether the lesion is superficial or deep, whether it has high-flow features, and whether the expected benefit justifies the risk of thermal injury. Active growth also means that treatment may suppress visible vascular tissue without eliminating the underlying biological tendency to enlarge.

During Involution

After involution, laser treatment is more commonly directed at residual superficial telangiectasias, persistent erythema, and selected pigmentary changes. At this point, the lesion may have little active tumour vascularity, so treatment is focused on remaining cutaneous abnormalities rather than on controlling rapid tumour expansion.

Residual fibrofatty tissue, redundant skin, or scarring will not necessarily respond to a vascular laser. Patients should be counselled that laser may improve colour without correcting all textural or contour changes.

Before Treating Uncertain Deep Lesions

A lesion with an unclear diagnosis or substantial subcutaneous involvement should not be treated solely on the basis of its colour. Colour-coded duplex sonography can assess vessel density, perfusion, flow characteristics, and depth; MRI may be useful when the lesion is deep, extensive, or anatomically complex.

Imaging is especially valuable when distinguishing a proliferating haemangioma from a vascular malformation, because these conditions have different natural histories and treatment objectives.

Distinguishing Haemangiomas from Vascular Malformations

Their Natural Histories Are Different

Infantile haemangiomas are usually absent or subtle at birth, enlarge rapidly during early infancy, and then undergo gradual involution. Vascular malformations are structural abnormalities that are generally present at birth, enlarge with the child, and do not spontaneously regress.

This distinction is fundamental. A treatment plan designed for a regressing tumour may be ineffective for a persistent venous or capillary malformation.

Clinical Clues Are Useful but Not Sufficient

Port-wine stains are typically present at birth as flat, macular areas of persistent redness. Infantile haemangiomas more often appear days or weeks after birth, although precursor marks may be visible earlier.

Rapid thickening and expansion favour an infantile haemangioma. Stable, flat colour without progressive tumour-like growth favours a capillary malformation, but atypical or deep lesions require imaging and specialist assessment.

Imaging Helps Resolve Ambiguity

A proliferating haemangioma generally demonstrates a well-defined, hypervascular lesion with spontaneous flow on duplex imaging. Vascular malformations may show different structural patterns, including dilated or multilocular vascular spaces and altered flow characteristics.

Correct classification prevents superficial laser treatment from being applied to a deep structural malformation where it cannot reach the relevant vessels or achieve adequate vessel collapse.

Understanding the Trade-offs

Early Treatment Is Not Automatically Better

Intervening during proliferation may be appropriate when growth threatens function, causes ulceration, or is likely to produce substantial deformity. However, many infantile haemangiomas have a natural tendency toward involution, and unnecessary laser exposure can cause avoidable injury.

The decision should balance the lesion’s expected natural course against its current and future risks.

Laser Does Not Treat Every Residual Feature

Vascular lasers are most effective when there is a suitable superficial vascular target. They are less likely to correct fibrofatty excess, redundant skin, deep residual tissue, or established contour deformity.

Expectations should therefore distinguish improvement in colour from complete restoration of normal skin.

Incorrect Diagnosis Can Lead to Ineffective Treatment

Treating a vascular malformation as an infantile haemangioma can result in repeated, superficial, or poorly targeted procedures. Treating a deep haemangioma with parameters intended for a superficial lesion can likewise produce limited benefit with unnecessary thermal damage.

Parameters Must Be Individualized

Fluence, pulse width, spot size, cooling, and treatment intervals should reflect vessel diameter, depth, skin type, anatomical site, and the lesion’s biological stage. These parameters cannot be selected reliably from colour alone.

How to Apply This to Laser Planning

The practical sequence is diagnosis first, biological staging second, and laser selection third.

• If your primary focus is controlling rapid growth: Confirm the diagnosis and depth promptly, involve an appropriate paediatric vascular-anomaly specialist, and do not assume laser is the primary treatment for an actively proliferating lesion.
• If your primary focus is treating ulceration or a high-risk site: Assess perfusion, tissue depth, anatomical function, and the risk of further thermal injury before selecting or combining therapies.
• If your primary focus is clearing residual redness: Wait until the lesion is clinically involuted or stable, then target persistent superficial telangiectasias with appropriately conservative vascular-laser parameters.
• If your primary focus is evaluating a deep or atypical lesion: Use colour-coded duplex sonography and, when indicated, MRI to distinguish a haemangioma from a vascular malformation before treatment.
• If your primary focus is achieving complete cosmetic correction: Explain that laser may improve residual vascular colour but may not remove fibrosis, fatty tissue, redundant skin, or contour changes.

Accurate staging allows laser treatment to address the right tissue, at the right time, with realistic expectations and controlled risk.

Summary Table:

Ensure precise, stage-appropriate laser treatment for your patients. Contact BELIS today to explore our advanced vascular and aesthetic laser systems, including diode, Nd:YAG, and IPL, designed for clinics and premium salons. Our expert team offers tailored solutions and clinical support to optimize outcomes. Contact us now to discuss your needs and elevate your practice.